His primary scientific interests are in Virology, Coronavirus, Antibody, Middle East respiratory syndrome coronavirus and Receptor. Lanying Du performs multidisciplinary study on Virology and Middle East respiratory syndrome in his works. His Antibody study is focused on Immunology in general.
His Immune system study in the realm of Immunology interacts with subjects such as Social stability. The various areas that Lanying Du examines in his Receptor study include Haplorhini, RNA interference, Viral structural protein and Microbiology. His Viral Vaccine research incorporates themes from HEK 293 cells, Plasma protein binding, Antiserum and Binding site.
Lanying Du spends much of his time researching Virology, Antibody, Coronavirus, Virus and Immunology. His Virology research includes elements of Immune system and Immunogenicity. His studies deal with areas such as Viral replication and Vaccination as well as Immune system.
His Antibody research is multidisciplinary, incorporating elements of Adjuvant and Antigen. His biological study spans a wide range of topics, including Spike Protein and Severe acute respiratory syndrome coronavirus 2. His Middle East respiratory syndrome coronavirus research incorporates elements of Middle East respiratory syndrome and Coronavirus Infections.
Lanying Du focuses on Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus, Antibody and 2019-20 coronavirus outbreak. Lanying Du incorporates Virology and Pneumonia in his research. His Severe acute respiratory syndrome coronavirus 2 research integrates issues from Middle East respiratory syndrome coronavirus and Pandemic.
His research investigates the connection between Coronavirus and topics such as Coronavirus Infections that intersect with issues in Human coronavirus and Betacoronavirus. His Antibody research includes themes of Adjuvant, In vitro, Immune system and Drug. As a part of the same scientific family, he mostly works in the field of 2019-20 coronavirus outbreak, focusing on Monoclonal antibody and, on occasion, Cross neutralization, Epitope and Antigen.
His main research concerns Coronavirus, Severe acute respiratory syndrome coronavirus 2, Virology, Antibody and 2019-20 coronavirus outbreak. His study of Coronavirus brings together topics like Nucleic acid amplification technique, Rhinovirus, Respiratory tract infections and Respiratory virus. Lanying Du combines subjects such as Middle East respiratory syndrome coronavirus and Severe acute respiratory syndrome coronavirus with his study of Severe acute respiratory syndrome coronavirus 2.
His Virology study frequently draws connections to other fields, such as Cell fusion. His Antibody study combines topics from a wide range of disciplines, such as HEK 293 cells, Receptor and Plasma protein binding. His Outbreak study integrates concerns from other disciplines, such as Unknown aetiology, Environmental health and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu.
Nature Reviews Microbiology (2009)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu.
Cellular & Molecular Immunology (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu.
Cell Research (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Shibo Jiang;Shibo Jiang;Christopher Hillyer;Lanying Du.
Trends in Immunology (2020)
Molecular mechanism for antibody-dependent enhancement of coronavirus entry
Yushun Wan;Jian Shang;Shihui Sun;Wanbo Tai.
Journal of Virology (2019)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan.
Nature Communications (2014)
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
Fei Yu;Lanying Du;David M. Ojcius;Chungen Pan.
Microbes and Infection (2020)
Recent advances in the detection of respiratory virus infection in humans
Naru Zhang;Lili Wang;Xiaoqian Deng;Ruiying Liang.
Journal of Medical Virology (2020)
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
Yang Yang;Lanying Du;Chang Liu;Lili Wang.
Proceedings of the National Academy of Sciences of the United States of America (2014)
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
Shibo Jiang;Shibo Jiang;Lanying Du;Zhengli Shi.
Emerging microbes & infections (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: